Kimberly-Clark is a global leader in personal care products, focusing on delivering essential health and hygiene solutions to consumers around the world. The company produces a wide range of well-known brands and products, including tissues, diapers, feminine hygiene products, and incontinence items, all aimed at improving daily life and ensuring comfort and protection for families. With a strong commitment to innovation and sustainability, Kimberly-Clark continually seeks to enhance its product offerings while reducing its environmental impact, making it a trusted name in household and personal care. Read More
Newell Brands (NASDAQ: NWL), the consumer goods giant behind household names like Rubbermaid, Sharpie, and Coleman, has once again declared a quarterly cash dividend of $0.07 per share, maintaining its payout to shareholders. The dividend, declared on November 10, 2025, is payable on December 15, 2025, to shareholders of
The massive deal has investors concerned, in part due to material issues after the U.S. government’s view that Kenvue’s Tylenol pain reliever causes a higher risk of autism.
Dallas, TX – November 6, 2025 – Valhi, Inc. (NYSE: VHI), a diversified holding company, has declared its regular quarterly dividend of $0.08 per share on its common stock. This announcement, made on November 6, 2025, with a record date of November 21, 2025, and a payment date of December 18,
Kimberly-Clark’s third quarter saw a positive response from the market as management highlighted volume and mix-led growth despite a flat sales environment. The company leveraged new product introductions and a focus on innovation across its product tiers to maintain market share in a competitive landscape. CEO Michael Hsu explained that “our inflection to volume plus mix-led growth that began last year continued into the third quarter,” attributing performance to meeting customers’ needs throughout the value spectrum. The company also benefited from strong productivity initiatives and a rewired organizational structure aimed at driving operational consistency.
BALA CYNWYD, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
A $38 billion partnership between Amazon and OpenAI reignited AI enthusiasm on Wall Street, sending tech stocks higher while the broader market faltered. Palantir impressed with record earnings, but most S&P 500 stocks closed in the red.
November 3, 2025 – The U.S. stock markets are experiencing a significant surge today, with both the S&P 500 and Nasdaq Composite pushing towards new highs. This bullish sentiment is largely fueled by two monumental corporate announcements: a strategic $38 billion partnership between Amazon Web Services (AWS) and OpenAI,
Shares of household products company Kimberly-Clark (NYSE:KMB)
fell 12.6% in the afternoon session after it announced a deal to acquire consumer health company Kenvue Inc. in a cash and stock transaction valued at approximately $48.7 billion. The deal involved both cash and stock, which meant that the ownership stake for existing Kimberly-Clark shareholders was set to be diluted; they were expected to own about 54% of the combined company. The market's harsh reaction also seemed tied to Kenvue's significant legal troubles. The maker of Tylenol and Band-Aid faced lawsuits, including allegations linking Tylenol to autism and legal action over talc cancer claims. These existing issues appeared to raise concerns among investors about the risks Kimberly-Clark was taking on. Adding to the uncertainty, an investor rights law firm launched an investigation into whether the merger was fair to Kimberly-Clark's shareholders.
The financial markets have kicked off the week with a significant surge, largely propelled by the blockbuster acquisition of Kenvue Inc. (NYSE: KVUE) by Kimberly-Clark Corporation (NYSE: KMB). This monumental $48.7 billion cash-and-stock deal, announced on November 3, 2025, has sent positive ripples through the stock market, particularly benefiting
